Literature DB >> 3356500

The pattern flash elicited P300-complex (PF-P300): a new method for studying cognitive processes of the brain.

A Taghavy1, C F Kügler.   

Abstract

For neurological purposes we developed a new method for eliciting P300-waves: Using two different kinds of checkerboard stimuli that were randomly flashed on a TV screen we obtained, besides the well-known usable primary complex, prominent PF-P300-complexes consisting of a marked negative potential (= N250), the PFP300a and the N400 peaks. These components could be related to different cognitive processes such as floating versus selective sustained attention and stimulus evaluation. N250 especially was shown to be closely related to different degrees of difficulty in visual discrimination. Further, the PFP300 components are test-retest reliable and sex-independent. Since they have relative small interindividual variabilities, we consider the N250- and PFP300a-latencies especially as well as the ascending PFP300a-amplitudes to be appropriate parameters for investigating diseases with cognitive disorders objectively.

Entities:  

Mesh:

Year:  1988        PMID: 3356500     DOI: 10.3109/00207458809000495

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.

Authors:  E A Jones; V I Giger-Mateeva; D Reits; F C Riemslag; B Liberov; H Spekrijse
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Cognitive impairment in asymptomatic cerebral arterial stenosis: a P300 study.

Authors:  Nevine El Nahas; Amr Zaki; Magd Zakaria; Azza Abd El Naser; Ahmed El Bassiony; Eman Abdeldayem; Hossam Shokri; Ahmed El Bokl
Journal:  Neurol Sci       Date:  2022-10-19       Impact factor: 3.830

3.  Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia.

Authors:  S Ozgocmen; T Yoldas; A Kamanli; H Yildizhan; R Yigiter; O Ardicoglu
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.